Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$18.33
▼ -2.55%
Market Cap
$808.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.90
52-Wk Range
16.65-31.26
CEO
Yongfeng Zhang
Country
US
Currency
USD
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product po…
Open full interactive analysis & DCF →